ERα expression in breast tumors from node-positive patients (23.3 ± 32.4%) appeared to be lower than in tumors from node-negative women (43.6 ± 34.2%), but this difference was not statistically significant (Mann–Whitney test, P = 0.065). Here, ESR1 is linked to breast neoplasm.